176 related articles for article (PubMed ID: 28722207)
1. Antihypertensive drug associated angioedema: effect modification by race/ethnicity.
Reichman ME; Wernecke M; Graham DJ; Liao J; Yap J; Chillarige Y; Southworth MR; Keeton S; Goulding MR; Mott K; Kelman JA
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1190-1196. PubMed ID: 28722207
[TBL] [Abstract][Full Text] [Related]
2. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme inhibitor-associated angioedema: higher risk in blacks than whites.
Burkhart DG; Brown NJ; Griffin MR; Ray WA; Hammerstrom T; Weiss S
Pharmacoepidemiol Drug Saf; 1996 May; 5(3):149-54. PubMed ID: 15073831
[TBL] [Abstract][Full Text] [Related]
4. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
[TBL] [Abstract][Full Text] [Related]
5. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
[TBL] [Abstract][Full Text] [Related]
6. Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink.
Mahmoudpour SH; Baranova EV; Souverein PC; Asselbergs FW; de Boer A; Maitland-van der Zee AH;
Br J Clin Pharmacol; 2016 Dec; 82(6):1647-1659. PubMed ID: 27524468
[TBL] [Abstract][Full Text] [Related]
7. Angioedema Among Hypertensive Patients Treated with Aliskiren or Other Antihypertensive Medications in the United States.
Schlienger RG; Korn JR; Wehler E; Lopez Leon S; Yeaw J
Am J Cardiovasc Drugs; 2017 Dec; 17(6):465-474. PubMed ID: 28779444
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis.
Shen JI; Saxena AB; Montez-Rath ME; Leng L; Chang TI; Winkelmayer WC
J Nephrol; 2017 Apr; 30(2):281-288. PubMed ID: 27485007
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors - a nationwide registry-based cohort study.
Rasmussen ER; Pottegård A; Bygum A; von Buchwald C; Homøe P; Hallas J
J Intern Med; 2019 May; 285(5):553-561. PubMed ID: 30618189
[TBL] [Abstract][Full Text] [Related]
10. Renin-Angiotensin-Aldosterone System-based Antihypertensive Agents and the Risk of Colorectal Cancer Among Medicare Beneficiaries.
Htoo PT; Stürmer T; Jonsson-Funk M; Pate V; Simpson RJ; Lund JL
Epidemiology; 2019 Nov; 30(6):867-875. PubMed ID: 31348009
[TBL] [Abstract][Full Text] [Related]
11. Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT).
Cohen JB; Marcum ZA; Zhang C; Derington CG; Greene TH; Ghazi L; Herrick JS; King JB; Cheung AK; Bryan N; Supiano MA; Sonnen JA; Weintraub WS; Scharfstein D; Williamson J; Pajewski NM; Bress AP;
JAMA Netw Open; 2022 Jul; 5(7):e2220680. PubMed ID: 35834254
[TBL] [Abstract][Full Text] [Related]
12. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors.
Miller DR; Oliveria SA; Berlowitz DR; Fincke BG; Stang P; Lillienfeld DE
Hypertension; 2008 Jun; 51(6):1624-30. PubMed ID: 18413488
[TBL] [Abstract][Full Text] [Related]
13. Angioedemas associated with renin-angiotensin system blocking drugs: Comparative analysis of spontaneous adverse drug reaction reports.
Dubrall D; Schmid M; Stingl JC; Sachs B
PLoS One; 2020; 15(3):e0230632. PubMed ID: 32214375
[TBL] [Abstract][Full Text] [Related]
14. Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker-Induced Angioedema.
Maroteau C; Siddiqui MK; Veluchamy A; Carr F; White M; Cassidy AJ; Baranova EV; Rasmussen ER; Eriksson N; Bloch KM; Brown NJ; Bygum A; Hallberg P; Karawajczyk M; Magnusson PKE; Yue QY; Syvänen AC; von Buchwald C; Alfirevic A; Maitland-van der Zee AH; Wadelius M; Palmer CNA;
Clin Pharmacol Ther; 2020 Dec; 108(6):1195-1202. PubMed ID: 32496628
[TBL] [Abstract][Full Text] [Related]
15. Angioedema related to Angiotensin inhibitors.
Knecht SE; Dunn SP; Macaulay TE
J Pharm Pract; 2014 Oct; 27(5):461-5. PubMed ID: 25124378
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature.
Brown T; Gonzalez J; Monteleone C
J Clin Hypertens (Greenwich); 2017 Dec; 19(12):1377-1382. PubMed ID: 28994183
[TBL] [Abstract][Full Text] [Related]
17. Comparison of diagnostic evaluations for cough among initiators of angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
Gokhale M; Girman C; Chen Y; Pate V; Funk MJ; Stürmer T
Pharmacoepidemiol Drug Saf; 2016 May; 25(5):512-20. PubMed ID: 26860956
[TBL] [Abstract][Full Text] [Related]
18. Effect of Race and Ethnicity on Antihypertensive Medication Utilization Among Women in the United States: Study of Women's Health Across the Nation (SWAN).
Jackson EA; Ruppert K; Derby CA; Lian Y; Neal-Perry G; Habel LA; Tepper PG; Harlow SD; Solomon DH
J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28232324
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment.
Rasmussen ER; Hallberg P; Baranova EV; Eriksson N; Karawajczyk M; Johansson C; Cavalli M; Maroteau C; Veluchamy A; Islander G; Hugosson S; Terreehorst I; Asselbergs FW; Norling P; Johansson HE; Kohnke H; Syvänen AC; Siddiqui MK; Lang CC; Magnusson PKE; Yue QY; Wadelius C; von Buchwald C; Bygum A; Alfirevic A; Maitland-van der Zee AH; Palmer CNA; Wadelius M
Pharmacogenomics J; 2020 Dec; 20(6):770-783. PubMed ID: 32080354
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension.
Kuan YC; Huang KW; Yen DJ; Hu CJ; Lin CL; Kao CH
Int J Cardiol; 2016 Oct; 220():462-6. PubMed ID: 27390970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
